Dizal Pharmaceutical
688192----
Current ValuationThe current P/E ratio is -45.20, below the reasonable range, cheaper than 97.44% of the time in the past 3 years, and the industry ranks 65/84, the industry Median 11.38.
-45.2xP/E
¥58.01Stock price
¥-1.28Earnings per share
-45.2xP/E
Stock price¥58.01Earnings per share¥-1.28
Historical Valuation
P/E ratioTypical rangeMedian
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 11.38x
03978117156
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 11.38x
0x40x80x120x160x200x
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.